Table 2 Economic burden of heart failure in South Korea in 2014
From: Prevalence and socio-economic burden of heart failure in an aging society of South Korea
Per-capita cost, USD | Total national cost, million USD | |||
|---|---|---|---|---|
Perspectives | Perspectives | |||
Payer | Society | Payer | Society | |
Total costs (direct and indirect costs) | 868.2 (100.0 %) | 1414.0 (100.0 %) | 412.4 (100.0 %) | 752.8 (100.0 %) |
Direct costs | 1347.8 (95.3 %) | 640.2 (85.0 %) | ||
NHI-covered medical costs | 868.2 (100.0 %) | 868.2 (61.4 %) | 412.4 (100.0 %) | 412.4 (54.8 %) |
Inpatient services (including prescription drug costs) | 463.3 (53.4 %) | 463.3 (32.8 %) | 220.1 (53.4 %) | 220.1 (29.2 %) |
Outpatient services (including prescription drug costs) | 404.9 (46.6 %) | 404.9 (28.6 %) | 192.3 (46.6 %) | 192.3 (25.6 %) |
Prescription drug costsa | 285.7 (32.9 %) | 285.7 (20.2 %) | 135.7 (32.9 %) | 135.7 (18.0 %) |
Non-NHI-covered medical costs | - | 217.0 (15.3 %) | - | 103.1 (13.7 %) |
Non-medical costs | - | 262.5 (18.6 %) | - | 124.7 (16.6 %) |
Transportation costs | 53.9 (3.8 %) | 25.6 (3.4 %) | ||
Caregiver’s costs | 208.7 (14.8 %) | 99.1 (13.2 %) | ||
Indirect costs | - | 66.3 (4.7 %) | - | 112.6 (15.0 %) |
PL due to morbidity | - | 66.3 (4.7 %) | - | 31.5 (4.2 %) |
PL due to premature death | - | - | - | 81.1 (10.8 %) |